Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cannabis and Opioid Use Disorder, Study 2
Sponsor: University of Kentucky
Summary
This inpatient study enrolls healthy individuals who have opioid use disorder. Participants live at the University of Kentucky Hospital for approx. 6 weeks. During this time, we will examine how repeated doses of oral cannabis and acute doses of oral and inhaled cannabis 1) modify the intensity and time course of opioid withdrawal, 2) modify the effects of intranasal opioid administration and 3) impact the safety of opioid administration.
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2026-07-30
Completion Date
2030-01-30
Last Updated
2026-06-26
Healthy Volunteers
No
Conditions
Interventions
Inhaled Cannabis
Participants will receive inhaled cannabis and placebo
Intranasal Opioid
Participants will receive intranasal opioids and placebo
Locations (1)
University of Kentucky
Lexington, Kentucky, United States